Fairfield, Bush & Co’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-655
| Closed | -$79.7K | – | 513 |
|
|
2023
Q4 | $79.7K | Buy |
+655
| New | +$73.1K | 0.05% | 168 |
|
|
2023
Q3 | – | Sell |
-4,715
| Closed | -$687K | – | 538 |
|
|
2023
Q2 | $687K | Hold |
4,715
| – | – | 0.19% | 93 |
|
|
2023
Q1 | $609K | Buy |
+4,715
| New | +$592K | 0.21% | 85 |
|
|
2022
Q3 | – | Sell |
-715
| Closed | -$75K | – | 487 |
|
|
2022
Q2 | $75K | Buy |
+715
| New | +$84.8K | 0.04% | 171 |
|
|
2021
Q4 | – | Sell |
-4,120
| Closed | -$585K | – | 162 |
|
|
2021
Q3 | $585K | Sell |
4,120
-6,429
| -61% | -$946K | 0.19% | 105 |
|
|
2021
Q2 | $1.64M | Buy |
10,549
+5,140
| +95% | +$833K | 0.45% | 49 |
|
|
2021
Q1 | $841K | Hold |
5,409
| – | – | 0.24% | 83 |
|
|
2020
Q4 | $809K | Hold |
5,409
| – | – | 0.24% | 84 |
|
|
2020
Q3 | $715K | Buy |
5,409
+206
| +4% | +$26.9K | 0.23% | 87 |
|
|
2020
Q2 | $603K | Hold |
5,203
| – | – | 0.22% | 87 |
|
|
2020
Q1 | $511K | Hold |
5,203
| – | – | 0.21% | 81 |
|
|
2019
Q4 | $756K | Sell |
5,203
-5
| -0.1% | -$690 | 0.28% | 77 |
|
|
2019
Q3 | $694K | Hold |
5,208
| – | – | 0.24% | 81 |
|
|
2019
Q2 | $595K | Hold |
5,208
| – | – | 0.2% | 87 |
|
|
2019
Q1 | $646K | Hold |
5,208
| – | – | 0.21% | 85 |
|
|
2018
Q4 | $524K | Hold |
5,208
| – | – | 0.18% | 94 |
|
|
2018
Q3 | $665K | Hold |
5,208
| – | – | 0.19% | 100 |
|
|
2018
Q2 | $563K | Hold |
5,208
| – | – | 0.17% | 101 |
|
|
2018
Q1 | $551K | Hold |
5,208
| – | – | 0.16% | 102 |
|
|
2017
Q4 | $610K | Buy |
5,208
+161
| +3% | +$18.2K | 0.17% | 100 |
|
|
2017
Q3 | $574K | Hold |
5,047
| – | – | 0.18% | 92 |
|
|
2017
Q2 | $629K | Hold |
5,047
| – | – | 0.2% | 80 |
|
|
2017
Q1 | $598K | Hold |
5,047
| – | – | 0.19% | 82 |
|
|
2016
Q4 | $506K | Hold |
5,047
| – | – | 0.16% | 95 |
|
|
2016
Q3 | $637K | Hold |
5,047
| – | – | 0.21% | 85 |
|
|
2016
Q2 | $590K | Hold |
5,047
| – | – | 0.2% | 79 |
|
|
2016
Q1 | $522K | Hold |
5,047
| – | – | 0.19% | 83 |
|
|
2015
Q4 | $503K | Buy |
5,047
+1,648
| +48% | +$161K | 0.18% | 92 |
|
|
2015
Q3 | $310K | Sell |
3,399
-4,120
| -55% | -$413K | 0.14% | 102 |
|
|
2015
Q2 | $797K | Hold |
7,519
| – | – | 0.24% | 82 |
|
|
2015
Q1 | $858K | Sell |
7,519
-41
| -0.5% | -$4.68K | 0.25% | 81 |
|
|
2014
Q4 | $833K | Hold |
7,560
| – | – | 0.24% | 81 |
|
|
2014
Q3 | $738K | Hold |
7,560
| – | – | 0.21% | 90 |
|
|
2014
Q2 | $762K | Buy |
+7,560
| New | +$738K | 0.22% | 88 |
|
|
2013
Q4 | – | Sell |
-6,592
| Closed | -$525K | – | 254 |
|
|
2013
Q3 | $525K | Hold |
6,592
| – | – | 0.16% | 100 |
|
|
2013
Q2 | $480K | Buy |
+6,592
| New | +$493K | 0.24% | 91 |
|
Other funds holding ZBH
Fairfield, Bush & Co's ZBH Position: Q1 2024 in Review
Fairfield, Bush & Co sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 655 shares — an estimated $79.7K sold.
Fairfield, Bush & Co first reported a position in ZBH in Q2 2013 and held it in 36 quarters. The position peaked at $1.64M in Q2 2021. 1,012 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.
- Fairfield, Bush & Co reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
- Fairfield, Bush & Co sold 655 Zimmer Biomet shares in Q1 2024, an estimated $79.7K.
- Fairfield, Bush & Co first reported a position in Zimmer Biomet in Q2 2013 and held it in 36 quarters.
- Fairfield, Bush & Co's Zimmer Biomet position peaked at $1.64M in Q2 2021.
- 1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.
Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.